HIVE's Mining Economics Look Sustainable on Paper, But Do Investors Still Believe the Model?

Hive Digital Technologies Ltd reports earnings on June 1, 2026, after market close, with analysts expecting another quarterly loss amid challenging conditions for the cryptocurrency mining sector. The central question is whether the company can demonstrate progress toward profitability as losses are projected to narrow sequentially, or if deteriorating fundamentals will continue to weigh on results. With the stock up sharply in recent weeks and analyst sentiment turning more cautious, the earnings release will test whether recent momentum can be sustained.

Part 1: Earnings Preview

Hive Digital Technologies Ltd is a cryptocurrency mining company focused on mining digital currencies including Bitcoin and Ethereum, operating data centers powered by green energy sources across Canada, Sweden, and Iceland. The company's performance is closely tied to cryptocurrency prices, mining difficulty, and operational efficiency.

HIVE reports earnings on June 1, 2026, after market close. Analysts expect a loss of $0.21 per share for the quarter ending March 2026, based on three estimates ranging from -$0.22 to -$0.20. The most recently reported quarter (December 2025) showed an actual loss of $0.18 per share. Year-over-year, the consensus estimate represents a 32.26% improvement compared to the $0.31 loss reported in the same quarter last year (March 2025), suggesting the company is making progress in narrowing its losses.

Three key themes define this earnings story:

1. Cryptocurrency Market Volatility and Mining Economics — Bitcoin and Ethereum price fluctuations directly impact HIVE's revenue generation and profitability. Investors will scrutinize whether recent crypto market conditions have improved mining economics enough to support the projected loss reduction, or if continued volatility has pressured margins.

2. Operational Efficiency and Cost Management — With losses expected to narrow both year-over-year and sequentially, the company's ability to control operating costs, optimize hash rate production, and improve energy efficiency will be critical. Any commentary on fleet upgrades, power costs, or operational improvements will be closely watched.

3. Balance Sheet Strength and Capital Allocation — As a capital-intensive business operating in a volatile sector, HIVE's cash position, debt levels, and strategy for equipment investment or cryptocurrency holdings will matter significantly. Investors will look for signs the company can weather market downturns while positioning for future growth.

Analyst commentary ahead of the release reflects cautious optimism tempered by sector headwinds, with estimates having improved from the prior consensus of -$0.31 to the current -$0.21, indicating analysts have become more constructive on near-term performance even as longer-term projections remain challenged.

Part 2: Historical Earnings Performance

HIVE has demonstrated an inconsistent earnings track record with a pattern of significant misses punctuated by occasional beats. Over the past four quarters, the company has missed estimates three times and beaten once, with the misses often substantial in magnitude.

The most severe disappointment came in March 2025, when HIVE reported a loss of $0.31 per share against expectations of -$0.11, representing a -181.82% surprise that shocked investors. The company followed with a +25.00% beat in June 2025 (reporting -$0.06 vs. -$0.08 expected), suggesting some operational improvement. However, the positive momentum proved short-lived as September 2025 brought another -100.00% miss (-$0.02 vs. -$0.01 expected), and the most recent December 2025 quarter delivered a -157.14% shortfall (-$0.18 vs. -$0.07 expected).

The pattern reveals a company struggling with forecasting accuracy and operational consistency, with three of the four most recent quarters showing actual losses more than double the consensus estimates. This track record suggests investors should approach the upcoming release with caution, as HIVE has repeatedly failed to meet even modest loss expectations despite analyst estimates already anticipating negative earnings.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

HIVE reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the first full session where the market reacts to actual earnings.

Historical price action around earnings shows moderate volatility with an average absolute Day 0 move of 3.76% and Day +1 move of 3.61%. The Day +1 range averages 9.09%, indicating significant intraday volatility as investors digest results.

The most dramatic reaction came in November 2024, when the stock dropped 10.88% on Day +1 with a 17.27% intraday range, demonstrating how disappointing results can trigger sharp selloffs. More recently, the November 2025 earnings brought a 9.56% Day 0 decline followed by a 7.55% Day +1 recovery with a 15.71% range, showing how the stock can whipsaw around releases. Most other quarters have seen more contained moves in the 1-4% range, though intraday ranges consistently exceed the closing moves, suggesting active trading and position adjustments throughout earnings days.

Part 2.2: Options Market Expected Move

The options market is pricing a 16.40% expected move (±$0.74, range $3.77-$5.25) for the upcoming earnings, which is significantly higher than the historical average Day +1 move of 3.61% and even exceeds the average Day +1 range of 9.09%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction, possibly reflecting heightened uncertainty around the company's ability to meet estimates given its inconsistent track record.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on HIVE with an average recommendation of 4.50 (between Buy and Strong Buy), though sentiment has recently deteriorated from 4.56 a month ago. The current consensus includes 6 Strong Buy ratings (down from 7 a month ago) and 2 Hold ratings, with no Sell or Strong Sell recommendations among the 8 analysts covering the stock.

The average price target of $5.73 implies 26.8% upside from the current price of $4.52, with estimates ranging from a low of $3.00 to a high of $10.00. This wide range reflects divergent views on the company's prospects, with the most optimistic analysts seeing more than double the upside of the consensus.

The recent downgrade of one Strong Buy rating and the slight decline in the average recommendation score signal growing caution among analysts, even as the overall stance remains constructive. This deterioration in sentiment comes despite the stock's strong recent price performance, suggesting analysts may be taking a more conservative view on valuation or expressing concerns about the sustainability of the rally heading into earnings.

Part 4: Technical Picture

HIVE enters earnings with strong technical momentum after a sharp rally. The Barchart Technical Opinion currently shows a 56% Buy signal, representing a dramatic improvement from a 56% Sell signal a month ago and strengthening from a 24% Buy just last week. This rapid shift reflects the stock's powerful uptrend.

The stock is trading above all key moving averages, a bullish configuration that confirms the strength of the recent advance. HIVE sits above its 5-day MA ($4.32), 10-day MA ($3.88), 20-day MA ($3.34), 50-day MA ($2.65), 100-day MA ($2.59), and 200-day MA ($3.21), with the shorter-term averages rising sharply above longer-term ones in a classic bullish alignment.

Timeframe Analysis:

• Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum with the stock in a strong uptrend
• Medium-term (Hold): Neutral reading suggests the intermediate trend is consolidating recent gains and lacks clear directional conviction
• Long-term (50% Buy): Moderate buy signal reflects improving but not yet fully established strength in the longer-term trend

Trend Characteristics: The Soft Strengthening trend indicates momentum is building but lacks the conviction of a mature uptrend, suggesting the rally may still be in its early stages or vulnerable to reversal on disappointing news.

The technical setup heading into earnings is supportive but extended. The stock has rallied more than 70% from its 50-day and 100-day moving averages, creating significant upside cushion but also raising the bar for a positive reaction. The 200-day MA at $3.21 now provides a key support level roughly 29% below current prices. With the stock above all moving averages and short-term momentum at maximum bullish readings, HIVE has room to run on good news, but the rapid advance also means any disappointment could trigger profit-taking. The medium-term Hold signal suggests the stock may need to consolidate recent gains, making the earnings release a potential catalyst for either a breakout continuation or a pullback to test support.